Principal Financial Group, Inc. (PFG)
NASDAQ: PFG · Real-Time Price · USD
75.53
-2.30 (-2.96%)
At close: Aug 1, 2025, 4:00 PM
76.42
+0.89 (1.18%)
After-hours: Aug 1, 2025, 7:57 PM EDT
Theseus Pharmaceuticals Stock Forecast
Stock Price Forecast
The 10 analysts that cover Theseus Pharmaceuticals stock have a consensus rating of "Hold" and an average price target of $86.9, which forecasts a 15.05% increase in the stock price over the next year. The lowest target is $72 and the highest is $101.
Price Target: $86.90 (+15.05%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Theseus Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 7 | 7 | 7 | 7 | 7 | 5 |
| Sell | 3 | 3 | 3 | 3 | 3 | 3 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Sell Maintains $73 → $72 | Sell | Maintains | $73 → $72 | -4.67% | Jul 30, 2025 |
| UBS | UBS | Hold Maintains $85 → $87 | Hold | Maintains | $85 → $87 | +15.19% | Jul 29, 2025 |
| Morgan Stanley | Morgan Stanley | Sell Maintains $71 → $75 | Sell | Maintains | $71 → $75 | -0.70% | Jul 14, 2025 |
| Wells Fargo | Wells Fargo | Sell Maintains $69 → $73 | Sell | Maintains | $69 → $73 | -3.35% | Jul 10, 2025 |
| Keefe, Bruyette & Woods | Keefe, Bruyette & Woods | Hold Maintains $87 → $90 | Hold | Maintains | $87 → $90 | +19.16% | Jul 9, 2025 |
Financial Forecast
Revenue This Year
16.47B
from 16.13B
Increased by 2.09%
Revenue Next Year
17.28B
from 16.47B
Increased by 4.97%
EPS This Year
8.15
from 6.68
Increased by 21.98%
EPS Next Year
9.14
from 8.15
Increased by 12.14%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 17.4B | 18.4B | 19.5B | |
| Avg | 16.5B | 17.3B | 18.5B | |
| Low | 15.6B | 16.2B | 17.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 8.1% | 11.8% | 13.0% | |
| Avg | 2.1% | 5.0% | 6.9% | |
| Low | -3.3% | -1.8% | 1.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 8.72 | 9.86 | 10.83 | |
| Avg | 8.15 | 9.14 | 10.05 | |
| Low | 7.60 | 8.26 | 9.19 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 30.5% | 21.0% | 18.5% | |
| Avg | 22.0% | 12.1% | 10.0% | |
| Low | 13.7% | 1.4% | 0.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.